Ferran Prat
Vorstandsvorsitzender bei Vitro SA
Profil
Ferran Prat is currently the CEO at Vitro SA. He is also the Director of the Business Unit at LETI Pharma SLU.
Additionally, he serves as a Board of Directors member at Advanced Marker Discovery SL and as an Advisor at CUBE Labs Srl.
Furthermore, he holds the position of Strategic Advisor at Zipprime Ltd.
and is a Partner at Ventac Partners AB.
In his former roles, Mr. Prat was the Director at Advanced Marker Discovery SL and Vice President at Werfen SA from 2017 to 2023.
He also served as the Vice President of Global Services at Dako Denmark ApS from 2009 to 2011 and as the Chief Operating Officer at Vivia Biotech SL.
Moreover, he worked as an Advisor at Vivia Biotech SL from 2013 to 2017.
Mr. Prat's education includes a graduate degree from The Trustees of Columbia University in The City of New York in 2006 and a graduate degree from Copenhagen Business School in 2004.
He also holds an undergraduate degree from the University of Barcelona and a graduate degree from Escuela de Alta Dirección y Administración.
Additionally, he obtained a graduate degree from Instituto de Estudios Superiores de la Empresa in 2020 and a graduate degree from EADA Business School in 1991.
Aktive Positionen von Ferran Prat
| Unternehmen | Position | Beginn |
|---|---|---|
LETI Pharma SLU
 LETI Pharma SLU Air Freight/CouriersTransportation Laboratorios LETI SL develops and produces pharmaceutical products. It offers dermatology, immunology and vaccines, diagnostics and oncology services. The company was founded by Pedro Domingo Sanjuán in 1919 and is headquartered in Barcelona, Spain. | Corporate Officer/Principal | - |
CUBE Labs Srl
 CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Berater | - |
Vitro SA
 Vitro SA Financial ConglomeratesFinance Vitro SA provides investment services. The private company is located in Mexico. Ferran Prat has been the CEO of the Mexican company since 2023. | Vorstandsvorsitzender | 01.01.2023 |
| Zipprime Ltd. | Berater | 01.01.2020 |
| Ventac Partners AB | Corporate Officer/Principal | 01.01.2018 |
Advanced Marker Discovery SL
 Advanced Marker Discovery SL Medical SpecialtiesHealth Technology Advanced Marker Discovery SL is a holding company engaged in the development of diagnostic solutions in the field of oncology. Its pipeline consists of tests for the prognosis and prediction of colon, lung, and prostate cancer. The company was founded on June 29, 2010 and is headquartered in Valladolid, Spain. | Direktor/Vorstandsmitglied | 01.01.2013 |
Ehemalige bekannte Positionen von Ferran Prat
| Unternehmen | Position | Ende |
|---|---|---|
Werfen SA
 Werfen SA Medical SpecialtiesHealth Technology Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain. | Vertrieb & Marketing | 01.07.2023 |
Vivia Biotech SL
 Vivia Biotech SL BiotechnologyHealth Technology Vivia Biotech SL provides biotechnology research services and laboratory instruments. It is a research and development company that focuses on the drug effects on hematological cancer patients. The firm provides personalized medicine test for blood cancers that can help predict the patient's response to treatment prior to its administration. The company was founded by Juan Antonio Ballesteros Nobell, Andrés Ballesteros Nobell and Fernando Rodríguez de Fonseca in September 2007 and is headquartered in Tres Cantos, Spain. | Berater | 30.11.2017 |
Vivia Biotech SL
Vivia Biotech SL BiotechnologyHealth Technology Vivia Biotech SL provides biotechnology research services and laboratory instruments. It is a research and development company that focuses on the drug effects on hematological cancer patients. The firm provides personalized medicine test for blood cancers that can help predict the patient's response to treatment prior to its administration. The company was founded by Juan Antonio Ballesteros Nobell, Andrés Ballesteros Nobell and Fernando Rodríguez de Fonseca in September 2007 and is headquartered in Tres Cantos, Spain. | Geschäftsführer | - |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Ferran Prat
| University of Barcelona | Undergraduate Degree |
| Escuela de Alta Dirección y Administración | Graduate Degree |
| EADA Business School | Graduate Degree |
| Copenhagen Business School | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Instituto de Estudios Superiores de la Empresa | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
Vivia Biotech SL
Vivia Biotech SL BiotechnologyHealth Technology Vivia Biotech SL provides biotechnology research services and laboratory instruments. It is a research and development company that focuses on the drug effects on hematological cancer patients. The firm provides personalized medicine test for blood cancers that can help predict the patient's response to treatment prior to its administration. The company was founded by Juan Antonio Ballesteros Nobell, Andrés Ballesteros Nobell and Fernando Rodríguez de Fonseca in September 2007 and is headquartered in Tres Cantos, Spain. | Health Technology |
Advanced Marker Discovery SL
Advanced Marker Discovery SL Medical SpecialtiesHealth Technology Advanced Marker Discovery SL is a holding company engaged in the development of diagnostic solutions in the field of oncology. Its pipeline consists of tests for the prognosis and prediction of colon, lung, and prostate cancer. The company was founded on June 29, 2010 and is headquartered in Valladolid, Spain. | Health Technology |
LETI Pharma SLU
LETI Pharma SLU Air Freight/CouriersTransportation Laboratorios LETI SL develops and produces pharmaceutical products. It offers dermatology, immunology and vaccines, diagnostics and oncology services. The company was founded by Pedro Domingo Sanjuán in 1919 and is headquartered in Barcelona, Spain. | Transportation |
Werfen SA
Werfen SA Medical SpecialtiesHealth Technology Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain. | Health Technology |
CUBE Labs Srl
CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Finance |
Vitro SA
Vitro SA Financial ConglomeratesFinance Vitro SA provides investment services. The private company is located in Mexico. Ferran Prat has been the CEO of the Mexican company since 2023. | Finance |
| Zipprime Ltd. | |
| Ventac Partners AB |
